New Evidence Available

Updated Recommendation

A new evidence synthesis was published:2025, WHO consolidated guidelines on tuberculosis: module 3: diagnosis

View latest version (2025)

Bibliographic information

GuidelineWHO consolidated guidelines on tuberculosis: module 3: diagnosis: rapid diagnostics for tuberculosis detection, 3rd ed.
Year of Publication2024
Issuing InstitutionWorld Health Organization

Recommendation

Retired

In adults and children with signs and symptoms of extrapulmonary TB, Xpert MTB/RIF or Xpert Ultra should be used for rifampicin-resistance detection rather than culture and phenotypic DST.

Recommended in favor

Strong

Notes and Remarks

Remarks Clinical judgement and pretest probability should guide treatment. In a high pretest probability setting, a negative test result will not rule out the condition.

Also Featured In

This recommendation also appears in the following guidelines:

Originally Developed
Guideline

WHO consolidated guidelines on tuberculosis: module 3: diagnosis – rapid diagnostics for tuberculosis detection: web annex 2. GRADE profiles

Year2020
InstitutionWHO
Guideline

WHO consolidated guidelines on tuberculosis: module 3: diagnosis – rapid diagnostics for tuberculosis detection: web annex 2. GRADE profiles

Year2020
InstitutionWHO